Trending Now
Latest News
FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract...
FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract InfectionsApril 24, 2024 -- Today, the U.S. Food and Drug...
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory...
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade GliomaBRISBANE, Calif., April 23, 2024 (GLOBE NEWSWIRE)...
More
FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract Infections
FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract InfectionsApril 24, 2024 -- Today, the U.S. Food and Drug...
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade...
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade GliomaBRISBANE, Calif., April 23, 2024 (GLOBE NEWSWIRE)...
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
Walgreens announced this week that it is expanding its specialty pharmacy offerings to include cell and gene therapy services. The move could allow Walgreens...
With All the Organ Donation Scrutiny, Ask: What Can We Do to Reduce the...
More than 90,000 Americans are waiting for a kidney transplant that could save their lives. Unfortunately, every day, 12 of those people die waiting...
Examining the Usefulness of the Lean Startup Method in Building Health Tech Products
Market research statistics indicate that more than 300 million startups are launched globally each year. Of that amount, only about 10% manage to become...
